{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T06:10:25Z","timestamp":1791526225377,"version":"4.3.4"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003172","name":"Henan University of Science and Technology","doi-asserted-by":"publisher","award":["266"],"award-info":[{"award-number":["266"]}],"id":[{"id":"10.13039\/501100003172","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical Pharmacology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.bcp.2026.117856","type":"journal-article","created":{"date-parts":[[2026,2,28]],"date-time":"2026-02-28T23:03:27Z","timestamp":1772319807000},"page":"117856","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Novel 1,2,3-triazole-based compound triggers apoptosis through DNA damage response involving ATM\/ATR signaling in liver cancer cells"],"prefix":"10.1016","volume":"248","author":[{"given":"Yao","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sisi","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yining","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiying","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.bcp.2026.117856_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.jceh.2024.102406","article-title":"Evolving Global Etiology of Hepatocellular Carcinoma (HCC): Insights and Trends for 2024","volume":"15","author":"Koshy","year":"2025","journal-title":"J. Clin. Exp. Hepatol."},{"issue":"2024","key":"10.1016\/j.bcp.2026.117856_b0010","first-page":"e474","article-title":"Hepatocellular carcinoma: signaling pathways, targeted therapy, and immunotherapy","volume":"5","author":"Luo","year":"2020","journal-title":"MedComm"},{"key":"10.1016\/j.bcp.2026.117856_b0015","doi-asserted-by":"crossref","first-page":"435","DOI":"10.2147\/JHC.S307962","article-title":"The Mechanisms of HBV-Induced Hepatocellular Carcinoma","volume":"8","author":"Jiang","year":"2021","journal-title":"J Hepatocell Carcinoma"},{"key":"10.1016\/j.bcp.2026.117856_b0020","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/nrc.2015.2","article-title":"DNA damage and the balance between survival and death in cancer biology","volume":"16","author":"Roos","year":"2016","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bcp.2026.117856_b0025","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.pbiomolbio.2019.06.003","article-title":"Structural insights into the critical DNA damage sensors DNA-PKcs, ATM and ATR","volume":"147","author":"Baretic","year":"2019","journal-title":"Prog. Biophys. Mol. Biol."},{"key":"10.1016\/j.bcp.2026.117856_b0030","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1080\/15384101.2016.1158362","article-title":"Structure of the human dimeric ATM kinase","volume":"15","author":"Lau","year":"2016","journal-title":"Cell Cycle"},{"key":"10.1016\/j.bcp.2026.117856_b0035","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.ccell.2021.02.014","article-title":"Therapeutic targeting of ATR yields durable regressions in small cell lung cancers with high replication stress","volume":"39","author":"Thomas","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.bcp.2026.117856_b0040","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.immuni.2013.06.014","article-title":"Mechanism of action of conventional and targeted anticancer therapies: reinstating immunosurveillance","volume":"39","author":"Zitvogel","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.bcp.2026.117856_b0045","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.202100158","article-title":"1,2,3-Triazole hybrids as anticancer agents: a review","volume":"355","author":"Alam","year":"2022","journal-title":"Arch Pharm (weinheim)"},{"key":"10.1016\/j.bcp.2026.117856_b0050","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/j.ejmech.2017.10.041","article-title":"Exploration of 1,2,3-triazole-pyrimidine hybrids as potent reversal agents against ABCB1-mediated multidrug resistance","volume":"143","author":"Wang","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bcp.2026.117856_b0055","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ejmech.2019.01.033","article-title":"Molecular diversity of trimethoxyphenyl-1,2,3-triazole hybrids as novel colchicine site tubulin polymerization inhibitors","volume":"165","author":"Fu","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.bcp.2026.117856_b0060","first-page":"279","article-title":"Hepatotoxicity of contemporary antiretroviral drugs, Curr Opin HIV","volume":"16","author":"Rivera","year":"2021","journal-title":"AIDS"},{"key":"10.1016\/j.bcp.2026.117856_b0065","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1265289","article-title":"Design and synthesis of cabotegravir derivatives bearing 1,2,3-triazole and evaluation of anti-liver cancer activity","volume":"14","author":"Xie","year":"2023","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.bcp.2026.117856_b0070","doi-asserted-by":"crossref","first-page":"2797","DOI":"10.1038\/sj.onc.1207532","article-title":"DNA damage-induced apoptosis","volume":"23","author":"Norbury","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/j.bcp.2026.117856_b0075","first-page":"771","article-title":"Cell Death Response to DNA damage","volume":"92","author":"Wang","year":"2019","journal-title":"Yale J. Biol. Med."},{"key":"10.1016\/j.bcp.2026.117856_b0080","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s10495-022-01780-7","article-title":"BCL-2 protein family: attractive targets for cancer therapy","volume":"28","author":"Kaloni","year":"2023","journal-title":"Apoptosis"},{"key":"10.1016\/j.bcp.2026.117856_b0085","doi-asserted-by":"crossref","first-page":"5805","DOI":"10.1007\/s12035-023-03433-5","article-title":"A Review on Caspases: Key regulators of Biological Activities and Apoptosis","volume":"60","author":"Sahoo","year":"2023","journal-title":"Mol. Neurobiol."},{"key":"10.1016\/j.bcp.2026.117856_b0090","first-page":"305","article-title":"Gamma-H2AX - a novel biomarker for DNA double-strand breaks","volume":"22","author":"Kuo","year":"2008","journal-title":"In Vivo"},{"key":"10.1016\/j.bcp.2026.117856_b0095","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s13148-011-0044-4","article-title":"H2AX phosphorylation at the sites of DNA double-strand breaks in cultivated mammalian cells and tissues, Clin","volume":"2","author":"Firsanov","year":"2011","journal-title":"Epigenetics"},{"key":"10.1016\/j.bcp.2026.117856_b0100","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1158\/1541-7786.MCR-19-0665","article-title":"An Emerging Regulatory Role for the Tumor Microenvironment in the DNA damage Response to Double-Strand Breaks","volume":"18","author":"Lama-Sherpa","year":"2020","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.bcp.2026.117856_b0105","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a012716","article-title":"DNA damage sensing by the ATM and ATR kinases","volume":"5","author":"Marechal","year":"2013","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.bcp.2026.117856_b0110","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.mrgentox.2008.08.017","article-title":"DNA repair and chromosomal alterations","volume":"657","author":"Natarajan","year":"2008","journal-title":"Mutat. Res."},{"key":"10.1016\/j.bcp.2026.117856_b0115","doi-asserted-by":"crossref","DOI":"10.3390\/genes12091370","article-title":"ATM's Role in the Repair of DNA Double-Strand Breaks","volume":"12","author":"Shibata","year":"2021","journal-title":"Genes (Basel)"},{"key":"10.1016\/j.bcp.2026.117856_b0120","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1007\/s00018-011-0666-x","article-title":"S-phase-coupled apoptosis in tumor suppression","volume":"68","author":"Cho","year":"2011","journal-title":"Cell. Mol. Life Sci."},{"key":"10.1016\/j.bcp.2026.117856_b0125","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18091979","article-title":"Genome Instability and gammaH2AX","volume":"18","author":"Georgoulis","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2026.117856_b0130","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.tcb.2015.07.009","article-title":"Repair Pathway choices and Consequences at the Double-Strand break","volume":"26","author":"Ceccaldi","year":"2016","journal-title":"Trends Cell Biol."},{"key":"10.1016\/j.bcp.2026.117856_b0135","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1247\/csf.14017","article-title":"Novel insights into Chk1 regulation by phosphorylation","volume":"40","author":"Goto","year":"2015","journal-title":"Cell Struct. Funct."},{"key":"10.1016\/j.bcp.2026.117856_b0140","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/978-94-017-9211-0_17","article-title":"Involvement of p53 in the repair of DNA double strand breaks: multifaceted Roles of p53 in homologous recombination repair (HRR) and non-homologous end joining (NHEJ)","volume":"85","author":"Menon","year":"2014","journal-title":"Subcell. Biochem."},{"key":"10.1016\/j.bcp.2026.117856_b0145","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1186\/s12935-021-02396-8","article-title":"p53 signaling in cancer progression and therapy","volume":"21","author":"Marei","year":"2021","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.bcp.2026.117856_b0150","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/s12935-023-02997-5","article-title":"SQLE Knockdown inhibits bladder cancer progression by regulating the PTEN\/AKT\/GSK3beta signaling pathway through P53","volume":"23","author":"Zou","year":"2023","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.bcp.2026.117856_b0155","doi-asserted-by":"crossref","first-page":"10248","DOI":"10.1002\/jcb.28309","article-title":"Crosstalk between Phosphoinositide 3-kinase\/Akt signaling pathway with DNA damage response and oxidative stress in cancer","volume":"120","author":"Karimian","year":"2019","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.bcp.2026.117856_b0160","doi-asserted-by":"crossref","DOI":"10.3390\/biom9110735","article-title":"Role of Reactive Oxygen Species in Cancer Progression: Molecular Mechanisms and recent Advancements","volume":"9","author":"Aggarwal","year":"2019","journal-title":"Biomolecules"},{"key":"10.1016\/j.bcp.2026.117856_b0165","article-title":"ROS-Induced mtDNA Release: the Emerging Messenger for Communication between Neurons and Innate Immune Cells during Neurodegenerative Disorder Progression","volume":"10","author":"Zhao","year":"2021","journal-title":"Antioxidants (basel)"},{"key":"10.1016\/j.bcp.2026.117856_b0170","doi-asserted-by":"crossref","DOI":"10.3390\/metabo13070796","article-title":"Cancer Metabolism: the Role of ROS in DNA damage and Induction of Apoptosis in Cancer Cells","volume":"13","author":"Zhao","year":"2023","journal-title":"Metabolites"},{"key":"10.1016\/j.bcp.2026.117856_b0175","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17081257","article-title":"Docosahexaenoic Acid Induces Oxidative DNA damage and Apoptosis, and Enhances the Chemosensitivity of Cancer Cells","volume":"17","author":"Song","year":"2016","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.bcp.2026.117856_b0180","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.jpha.2023.03.006","article-title":"Ginsenoside Rk3 is a novel PI3K\/AKT-targeting therapeutics agent that regulates autophagy and apoptosis in hepatocellular carcinoma","volume":"13","author":"Qu","year":"2023","journal-title":"J. Pharm. Anal."},{"key":"10.1016\/j.bcp.2026.117856_b0185","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1186\/s13046-025-03531-3","article-title":"Bufalin inhibits hepatocellular carcinoma progression by blocking EGFR-mediated RAS-RAF-MEK-ERK pathway activation","volume":"44","author":"Liu","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."}],"container-title":["Biochemical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226001887?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006295226001887?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T06:27:58Z","timestamp":1777444078000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006295226001887"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":37,"alternative-id":["S0006295226001887"],"URL":"https:\/\/doi.org\/10.1016\/j.bcp.2026.117856","relation":{},"ISSN":["0006-2952"],"issn-type":[{"value":"0006-2952","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel 1,2,3-triazole-based compound triggers apoptosis through DNA damage response involving ATM\/ATR signaling in liver cancer cells","name":"articletitle","label":"Article Title"},{"value":"Biochemical Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bcp.2026.117856","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"117856"}}